191 related articles for article (PubMed ID: 31180641)
1. Familial L723P Mutation Can Shift the Distribution between the Alternative APP Transmembrane Domain Cleavage Cascades by Local Unfolding of the Ε-Cleavage Site Suggesting a Straightforward Mechanism of Alzheimer's Disease Pathogenesis.
Bocharov EV; Nadezhdin KD; Urban AS; Volynsky PE; Pavlov KV; Efremov RG; Arseniev AS; Bocharova OV
ACS Chem Biol; 2019 Jul; 14(7):1573-1582. PubMed ID: 31180641
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production.
Dimitrov M; Alattia JR; Lemmin T; Lehal R; Fligier A; Houacine J; Hussain I; Radtke F; Dal Peraro M; Beher D; Fraering PC
Nat Commun; 2013; 4():2246. PubMed ID: 23907250
[TBL] [Abstract][Full Text] [Related]
3. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
[TBL] [Abstract][Full Text] [Related]
4. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
5. Increased H-Bond Stability Relates to Altered ε-Cleavage Efficiency and Aβ Levels in the I45T Familial Alzheimer's Disease Mutant of APP.
Götz A; Högel P; Silber M; Chaitoglou I; Luy B; Muhle-Goll C; Scharnagl C; Langosch D
Sci Rep; 2019 Mar; 9(1):5321. PubMed ID: 30926830
[TBL] [Abstract][Full Text] [Related]
6. Modulating Hinge Flexibility in the APP Transmembrane Domain Alters γ-Secretase Cleavage.
Götz A; Mylonas N; Högel P; Silber M; Heinel H; Menig S; Vogel A; Feyrer H; Huster D; Luy B; Langosch D; Scharnagl C; Muhle-Goll C; Kamp F; Steiner H
Biophys J; 2019 Jun; 116(11):2103-2120. PubMed ID: 31130234
[TBL] [Abstract][Full Text] [Related]
7. Dissecting conformational changes in APP's transmembrane domain linked to ε-efficiency in familial Alzheimer's disease.
Götz A; Scharnagl C
PLoS One; 2018; 13(7):e0200077. PubMed ID: 29966005
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
[TBL] [Abstract][Full Text] [Related]
9. beta-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations.
McPhie DL; Golde T; Eckman CB; Yager D; Brant JB; Neve RL
Brain Res Mol Brain Res; 2001 Dec; 97(1):103-13. PubMed ID: 11744168
[TBL] [Abstract][Full Text] [Related]
10. Mutations in APP have independent effects on Abeta and CTFgamma generation.
Hecimovic S; Wang J; Dolios G; Martinez M; Wang R; Goate AM
Neurobiol Dis; 2004 Nov; 17(2):205-18. PubMed ID: 15474359
[TBL] [Abstract][Full Text] [Related]
11. Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the γ-secretase cleavage sites.
Yan Y; Xu TH; Harikumar KG; Miller LJ; Melcher K; Xu HE
J Biol Chem; 2017 Sep; 292(38):15826-15837. PubMed ID: 28790170
[TBL] [Abstract][Full Text] [Related]
12. Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants.
Gorman PM; Kim S; Guo M; Melnyk RA; McLaurin J; Fraser PE; Bowie JU; Chakrabartty A
BMC Neurosci; 2008 Jan; 9():17. PubMed ID: 18234110
[TBL] [Abstract][Full Text] [Related]
13. Specific Mutations near the Amyloid Precursor Protein Cleavage Site Increase γ-Secretase Sensitivity and Modulate Amyloid-β Production.
Suzuki R; Takahashi H; Yoshida C; Hidaka M; Ogawa T; Futai E
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835396
[TBL] [Abstract][Full Text] [Related]
14. Perturbations of the straight transmembrane α-helical structure of the amyloid precursor protein affect its processing by γ-secretase.
Lemmin T; Dimitrov M; Fraering PC; Dal Peraro M
J Biol Chem; 2014 Mar; 289(10):6763-6774. PubMed ID: 24469457
[TBL] [Abstract][Full Text] [Related]
15. The amyloid peptide precursor in Alzheimer's disease.
Octave JN
Acta Neurol Belg; 1995 Dec; 95(4):197-209. PubMed ID: 8553793
[TBL] [Abstract][Full Text] [Related]
16. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway.
Haass C; Lemere CA; Capell A; Citron M; Seubert P; Schenk D; Lannfelt L; Selkoe DJ
Nat Med; 1995 Dec; 1(12):1291-6. PubMed ID: 7489411
[TBL] [Abstract][Full Text] [Related]
17. [Molecular basics of Alzheimer's disease].
Grigorenko AP; Rogaev EI
Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of amyloid precursor protein sorting with pathological mutations results in a distinct effect on amyloid-β production.
Lin YC; Wang JY; Wang KC; Liao JY; Cheng IH
J Neurochem; 2014 Nov; 131(4):407-12. PubMed ID: 25053581
[TBL] [Abstract][Full Text] [Related]
19. Bacterial and cell-free production of APP671-726 containing amyloid precursor protein transmembrane and metal-binding domains.
Bocharova OV; Urban AS; Nadezhdin KD; Bocharov EV; Arseniev AS
Biochemistry (Mosc); 2013 Nov; 78(11):1263-71. PubMed ID: 24460940
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
